Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
boston blog main
boston top stories
cancer drugs
4
×
deals
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
amgen
cancer
clinical trials
national
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
investing
ipo
medical device
medicare
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
What
bio
cancer
drug
hasn’t
ipo
research
roundup
week
acquisitions
appetite
arrival
biggest
biotech
black
bread
build
butter
buy
buyout
cash
ceo
companies
company’s
daniel
days
debut
despite
diabetes
diamond’s
drugs
dyne’s
eli
family
giant
gilead
grabbed
hardest
hit
hold
hottest
Language
unset
Current search:
photo
×
deals
×
" cancer drugs "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More